Teva Says Fed. Circ. Made Skinny Label Law ‘A Dead Letter’
In 2007, Teva launched its drug, carving out the patent-protected indication of congestive heart failure, leaving the indications on the drug’s label for just …
In: PATENT NEWS
In 2007, Teva launched its drug, carving out the patent-protected indication of congestive heart failure, leaving the indications on the drug’s label for just …
In: PATENT NEWS
McFadyen, a registered patent attorney and formerly of Akerman LLP, plans to work in Polsinelli’s biotechnology and life sciences patent prosecution …
In: PATENT NEWS
In a 17-page order, U.S. District Judge Leonard P. Stark dismissed Blix’s federal Sherman Act claims without prejudice, finding that Blix did not allege …
In: PATENT NEWS
ACI Law Group PC on Monday lodged the suit in California federal court against ACI Law Group PLLC, a law firm started last year by Arizona attorney …
In: PATENT NEWS
Law professors and a membership group focused on drug pricing are weighing in on a Supreme Court case where the future of Patent Trial and …
In: PATENT NEWS
On November 3, 2014, three intellectual property law courts were established including Beijing, Shanghai and Guangzhou to hear first instance …
In: PATENT NEWS
Webinar. The Annual Berkeley-Stanford Advanced Patent Law Institute (APLI) is co-organized by BCLT and Stanford Law School and presents a roster …
In: PATENT NEWS
The U.S. Patent and Trademark Office may advance policy goals less friendly to patent owners if President-elect Joe Biden’s Commerce Department …
In: PATENT NEWS
… Law Association, Landau said Monday that the board’s use of discretionary denials has increased the frequency of patent litigation and driven up its …
In: PATENT NEWS
Kentucky Attorney General Daniel Cameron (R) may join a lawsuit … The U.S. Patent and Trademark Office may advance policy goals less friendly to …
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION